Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|
| Revenue | 6 | 7↑24.2% | 0 | 0 |
| Gross Profit | 6 | 7↑24.2% | -2↓124.3% | -2↓25.0% |
| Operating Income | -26 | -29↓11.5% | -62↓112.4% | -143↓128.5% |
| Net Income | -26 | -29↓9.7% | -60↓108.9% | -127↓111.2% |
| EBITDA | -26 | -28↓7.8% | -58↓110.5% | -125↓114.1% |
| EPS Diluted | -1.02 | -1.12↓9.8% | -0.00↑100.0% | -3.33↓3329900.0% |